LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Remedy Plan Therapeutics…

Remedy Plan Therapeutics Tech Stack

Remedy Plan Therapeutics uses 8 technology products and services including Wix eCommerce, Microsoft Outlook, Lodash, and more. Explore Remedy Plan Therapeutics's tech stack below.

  • Wix eCommerce
    E-commerce
  • Microsoft Outlook
    Email
  • Lodash
    Javascript Libraries
  • Microsoft Word
    Office Suites
  • WordPress.com
    Platform As A Service
  • Google Tag Manager
    Tag Management
  • YouTube
    Video Players
  • Piwik PRO Core
    Web Analytics

Media & News

Remedy Plan Therapeutics's Email Address Formats

Remedy Plan Therapeutics uses at least 1 format(s):
Remedy Plan Therapeutics Email FormatsExamplePercentage
First@remedyplan.comJohn@remedyplan.com
82%
Last@remedyplan.comDoe@remedyplan.com
13%
FLast@remedyplan.comJDoe@remedyplan.com
5%

Frequently Asked Questions

Where is Remedy Plan Therapeutics's headquarters located?

Minus sign iconPlus sign iconRemedy Plan Therapeutics's main headquarters is located at Gaithersburg, Maryland United States. The company has employees across 2 continents, including North AmericaEurope.

What is Remedy Plan Therapeutics's official website and social media links?

Minus sign iconPlus sign iconRemedy Plan Therapeutics's official website is remedyplan.com and has social profiles on LinkedInCrunchbase.

What is Remedy Plan Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconRemedy Plan Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Remedy Plan Therapeutics have currently?

Minus sign iconPlus sign iconAs of June 2026, Remedy Plan Therapeutics has approximately 16 employees across 2 continents, including North AmericaEurope. Key team members include Cfo/Cbo: J. M.Chief Scientific Officer: M. S.Chief Operations Officer: D. A. D. J.. Explore Remedy Plan Therapeutics's employee directory with LeadIQ.

What industry does Remedy Plan Therapeutics belong to?

Minus sign iconPlus sign iconRemedy Plan Therapeutics operates in the Biotechnology Research industry.

What technology does Remedy Plan Therapeutics use?

Minus sign iconPlus sign iconRemedy Plan Therapeutics's tech stack includes Wix eCommerceMicrosoft OutlookLodashMicrosoft WordWordPress.comGoogle Tag ManagerYouTubePiwik PRO Core.

What is Remedy Plan Therapeutics's email format?

Minus sign iconPlus sign iconRemedy Plan Therapeutics's email format typically follows the pattern of First@remedyplan.com. Find more Remedy Plan Therapeutics email formats with LeadIQ.

How much funding has Remedy Plan Therapeutics raised to date?

Minus sign iconPlus sign icon As of June 2026, Remedy Plan Therapeutics has raised $18M in funding. The last funding round occurred on May 13, 2025 for $18M.

When was Remedy Plan Therapeutics founded?

Minus sign iconPlus sign iconRemedy Plan Therapeutics was founded in 2016.

Remedy Plan Therapeutics

Biotechnology ResearchMaryland, United States11-50 Employees

Remedy Plan Therapeutics is a small biotechnology company based in Gaithersburg, Maryland, focused on developing therapies that modulate NAMPT activity. It pursues a tunable, hyperbolic NAMPT inhibition approach intended to minimize on-target toxicity while addressing dysregulation associated with multiple conditions. The company is building a pipeline of NAMPT inhibitors aimed at solid tumors, hematologic malignancies, obesity, and autoimmune disorders. 

Its lead candidate, RPT1G, has progressed into clinical development, with results from a first-in-human Phase 1 healthy volunteer study announced in December 2025. Remedy Plan operates within the biotechnology research industry from its Gaithersburg headquarters.

Section iconCompany Overview

Headquarters
Gaithersburg, Maryland United States
Website
remedyplan.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $18M

    Remedy Plan Therapeutics has raised a total of $18M of funding over 7 rounds. Their latest funding round was raised on May 13, 2025 in the amount of $18M.

  • $1M$10M

    Remedy Plan Therapeutics's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $18M

    Remedy Plan Therapeutics has raised a total of $18M of funding over 7 rounds. Their latest funding round was raised on May 13, 2025 in the amount of $18M.

  • $1M$10M

    Remedy Plan Therapeutics's revenue is estimated to be in the range of $1M$10M

Company Leadership

  • Stylized image of a person
    J. M.
    Cfo/Cbo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. S.
    Chief Scientific Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. A. D. J.
    Chief Operations Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. J.
    Chief Operations Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    G. C.
    Founder And Ceo
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    D. J.
    Chief Operations Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    E. V.
    Director, Head Of Clinical Trial Operations
    Phone icon
    Mobile Phone
  • Stylized image of a person
    P. M.
    Program Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. R.
    Senior Project Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. L.
    Digital Technology Lead
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.